IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
IGF-I rescues diabetic heart defects and oxidative stress, although the underlying mechanism of action remains poorly understood. This study was designed to delineate the beneficial effects of IGF-I with a focus on RhoA, Akt, and eNOS coupling. Echocardiography was performed in normal or diabetic Friend Virus-B type (FVB) and IGF-I transgenic mice. Cardiomyocyte contractile properties were evaluated using peak shortening (PS), time-to-90% relengthening (TR 90), and intracellular Ca 2+ rise and decay. Diabetes reduced fraction shortening, PS, and intracellular Ca 2+; it increased chamber size, prolonged TR 90, and intracellular Ca 2+ decay. Levels of RhoA mRNA, active RhoA, and O 2− were elevated, whereas nitric oxide (NO) levels were reduced in diabetes. Diabetes-induced O 2− accumulation was ablated by the NO synthase (NOS) inhibitor nitro-l-arginine methyl ester (l-NAME), indicating endothelial NOS (eNOS) uncoupling, all of which except heart size were negated by IGF-I. The IGF-I-elicited beneficial effects were mimicked by the Rho kinase inhibitor Y27632 and BH 4. Diabetes depressed expression of Kv 1.2 and dihydrofolate reductase (DHFR), increased β-myosin heavy-chain expression, stimulated p38 MAPK, and reduced levels of total Akt and phosphorylated Akt/eNOS, all of which with the exception of myosin heavy chain were attenuated by IGF-I. In addition, Y27632 and the eNOS coupler folate abrogated glucose toxicity-induced PS decline, TR 90 prolongation, while it increased O 2− and decreased NO and Kv 1.2 levels. The DHFR inhibitor methotrexate impaired myocyte function, NO/O 2− balance, and rescued Y27632-induced cardiac protection. These results revealed that IGF-I benefits diabetic hearts via Rho inhibition and antagonism of diabetes-induced decrease in pAkt, eNOS uncoupling, and K+ channel expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhao, H., Kalivendi, S., Zhang, H., Joseph, J., Nithipatikom, K., Vásquez-Vivar, J., & Kalyanaraman, B. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00142-4 · Cited by 803
Ye, G., Metreveli, N. S., Ren, J., & Epstein, P. N. (2003) · Diabetes · doi:10.2337/diabetes.52.3.777 · Cited by 180
Self-citation
Cited by
The intersection between aging and cardiovascular disease
North, B. J., & Sinclair, D. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.246876 · Cited by 1,585
Varga, Z. V., Giricz, Z., Liaudet, L., Haskó, G., Ferdinandy, P., & Pacher, P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.030 · Cited by 286
Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy
Kaludercic, N., & Di Lisa, F. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00012 · Cited by 263
Tetrahydrobiopterin in Cardiovascular Health and Disease
Bendall, J. K., Douglas, G., McNeill, E., Channon, K. M., & Crabtree, M. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5566 · Cited by 231
“The importance of DHFR activity in vivo was has been investigated in mice after the inhibition of DHFR with MTX.”
InfluentialCrabtree, M. J., Tatham, A. L., Hale, A. B., Alp, N. J., & Channon, K. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041483 · Cited by 210
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
Salvatore, T., Pafundi, P. C., Galiero, R., Albanese, G., Di Martino, A., Caturano, A., Vetrano, E., Rinaldi, L., & Sasso, F. C. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.695792 · Cited by 165
“IGF-I is a crucial cardiac survival factor that downregulating RhoA produces beneficial effects also mimicked by the Rho kinase inhibitor Y27632 and BH4, a finding indicating that the selective IGF-I overexpression may represent a therapeutic potential for DM-CMP (80).”
BackgroundNitric Oxide Synthases in Heart Failure
Carnicer, R., Crabtree, M. J., Sivakumaran, V., Casadei, B., & Kass, D. A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4824 · Cited by 163
“For example, DHFR protein levels are significantly decreased in streptozotocin-induced diabetic mice, and diabetes-induced impairment of cardiomyocyte function is exacerbated after DHFR inhibition with methotrexate (186).”
Ionova, I. A., Vásquez-Vivar, J., Whitsett, J., Herrnreiter, A., Medhora, M., Cooley, B. C., & Pieper, G. M. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00748.2008 · Cited by 35
Roe, N. D., He, E. Y., Wu, Z., & Ren, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.042 · Cited by 35
“NO2-free H2O was used as negative control [21].”
BackgroundMethodSelf-citation
Metadata
- Authors
- Ren, J., Duan, J., Thomas, D. P., Yang, X., Sreejayan, N., Sowers, J. R., Leri, A., Kajstura, J., Gao, F., & Anversa, P.
- Venue
- American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Publisher
- American Physiological Society
- Published
- 2008-03
- Volume
- 294
- Issue
- 3
- Pages
- R793-R802
- ISSN
- 0363-6119 (ISSN-L)
- 1522-1490
- OpenAlex
- W2121815457
- Cited by
- 63
- References
- 2
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.